查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1692359

马用药品和补品市场 - 全球产业规模、份额、趋势、机会和预测，按产品、配销通路、地区和竞争细分，2020-2030 年预测

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球马用药品和补充剂市场价值为 9.7289 亿美元，预计在预测期内将经历大幅增长，到 2030 年预计年复合成长率(CAGR) 为 5.90%。该市场包括旨在促进马匹健康和福祉的各种产品和服务。它涵盖专为马匹设计的药品、营养补充剂和医疗保健服务，目的是维持马匹的健康、提高马匹的性能并解决各种医疗状况。例如，2024年3月，美国马兽医协会（AAEP）发布了针对美国流行的五种重大马病的更新疫苗接种方案，这些疾病——西尼罗河病毒、破伤风、马脑脊髓炎和狂犬病——的方案旨在加强预防工作，确保全国马匹的健康和安全。

市场概况
预测期 2026-2030
2024 年市场规模 9.7289亿美元
2030 年市场规模 13.6115亿美元
2025-2030 年复合年增长率 5.90％
成长最快的领域 製药
最大的市场 北美洲

主要市场驱动因素：

增加马匹数量

主要市场挑战：

仿冒品

主要市场趋势：

天然和草药补充剂

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球马用药品和补品市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（药品、补品）
    • 按配销通路（药局、兽医院、其他）
    • 按地区
    • 按公司分类（2024）
  • 产品市场图
    • 按产品
    • 按配销通路
    • 按地区

第六章：北美马用药品和补品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲马用药品和补品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太地区马用药品和补品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 日本
    • 印度
    • 澳洲
    • 韩国

第九章：南美马用药品及补品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲马用药品和补品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Merck & Co Inc
  • Elanco Animal Health Inc
  • Bayer AG
  • Ceva Sante Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Affymetrix Inc
  • Celltrion Inc

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 18814

The global Equine Pharmaceuticals & Supplements market was valued at USD 972.89 million in 2024 and is expected to experience substantial growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market includes a wide range of products and services aimed at promoting the health and well-being of horses. It encompasses pharmaceuticals, nutritional supplements, and healthcare services specifically designed for equines, with the goal of maintaining their health, improving performance, and addressing various medical conditions. For example, in March 2024, the American Association of Equine Practitioners (AAEP) released updated vaccination protocols for five critical equine diseases prevalent in the U.S. These diseases-West Nile virus, tetanus, equine encephalomyelitis, and rabies-have protocols designed to improve prevention efforts and ensure the health and safety of horses nationwide.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 972.89 Million
Market Size 2030USD 1361.15 Million
CAGR 2025-20305.90%
Fastest Growing SegmentPharmaceutical
Largest MarketNorth America

Key Market Drivers:

Increasing Equine Population

The global equine industry has seen a notable and steady rise in the equine population, which has significantly influenced the growth of the Equine Pharmaceuticals & Supplements market. There has been a marked increase in participation in equestrian activities such as horse riding, show jumping, and dressage, leading to a higher demand for horses for both sporting and recreational purposes. Beyond sports and leisure, horses are vital in industries such as agriculture, tourism, therapy, and law enforcement. As these sectors grow, the need for a larger equine workforce has also increased. Additionally, horses have become increasingly popular as companion animals, contributing to a surge in ownership.

Key Market Challenges:

Counterfeit Products

The presence of counterfeit equine pharmaceuticals and supplements remains a significant challenge. These products are often of subpar quality, containing incorrect ingredients or dosages, which could endanger the health of horses and undermine consumer confidence in the market.

Key Market Trends:

Natural and Herbal Supplements

A growing trend within the equine supplements market is the rising demand for natural and herbal alternatives. Horse owners are increasingly seeking holistic solutions to equine health, opting for supplements made from herbs, botanicals, and plant-based ingredients known for their therapeutic benefits. These products are perceived as gentler alternatives to conventional pharmaceuticals.

Key Market Players:

  • Zoetis Inc
  • Boehringer Ingelheim GmbH
  • Merck & Co Inc
  • Elanco Animal Health Inc
  • Bayer AG
  • Ceva Sante Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Affymetrix Inc
  • Celltrion Inc

Report Scope:

This report segments the global Equine Pharmaceuticals & Supplements market into the following categories, and provides insights into the industry trends:

By Product:

  • Pharmaceuticals
  • Supplements

By Distribution Channel:

  • Drug Stores
  • Veterinary Hospitals
  • Other Channels

By Region:

  • North America: United States, Canada, Mexico
  • Europe: Germany, United Kingdom, France, Italy, Spain
  • Asia-Pacific: China, Japan, India, Australia, South Korea
  • South America: Brazil, Argentina, Colombia
  • Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides a detailed analysis of the key players in the global Equine Pharmaceuticals & Supplements market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the Global Equine Pharmaceuticals & Supplements market, catering to individual business needs. Customization options include the profiling and analysis of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Pharmaceuticals & Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Pharmaceutical, Supplement)
    • 5.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Equine Pharmaceuticals & Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Pharmaceutical, Supplement)
    • 6.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Pharmaceuticals & Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Equine Pharmaceuticals & Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Equine Pharmaceuticals & Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Distribution Channel

7. Europe Equine Pharmaceuticals & Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Pharmaceutical, Supplement)
    • 7.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Equine Pharmaceuticals & Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. United Kingdom Equine Pharmaceuticals & Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. France Equine Pharmaceuticals & Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Equine Pharmaceuticals & Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Equine Pharmaceuticals & Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Equine Pharmaceuticals & Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Pharmaceutical, Supplement)
    • 8.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Pharmaceuticals & Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. Japan Equine Pharmaceuticals & Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. India Equine Pharmaceuticals & Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. Australia Equine Pharmaceuticals & Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. South Korea Equine Pharmaceuticals & Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Distribution Channel

9. South America Equine Pharmaceuticals & Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Pharmaceutical, Supplement)
    • 9.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Pharmaceuticals & Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Equine Pharmaceuticals & Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Equine Pharmaceuticals & Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Equine Pharmaceuticals & Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Pharmaceutical, Supplement)
    • 10.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Pharmaceuticals & Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Pharmaceuticals & Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Equine Pharmaceuticals & Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Distribution Channel
    • 10.3.4. Kuwait Equine Pharmaceuticals & Supplements Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Zoetis Inc
  • 14.2. Boehringer Ingelheim GmbH
  • 14.3. Merck & Co Inc
  • 14.4. Elanco Animal Health Inc
  • 14.5. Bayer AG
  • 14.6. Ceva Sante Animale SA
  • 14.7. Virbac SA
  • 14.8. Vetoquinol SA
  • 14.9. Affymetrix Inc
  • 14.10. Celltrion Inc

15. Strategic Recommendations

16. About Us & Disclaimer